EGFRvIII peptide (PEPvIII)
*This product has been discontinued!*
The epidermal growth factor receptor variant III (EGFRvIII) is a consistent tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms. As such it represents a truly tumor-specific target for antitumor immunotherapy.
| RP20356 | |
|
|
|
|
|
|
| Ask us a question | |